Literature DB >> 29749241

miRNA-489 as a biomarker in diagnosis and treatment of cervical cancer.

C Juan, Q Hua, Z Ruping, W Tingting.   

Abstract

miRNA-489 was shown to be a suppressor factor in many cancers, however, evidence on the effects and mechanism of miRNA-489 in progression of cervical cancer is limited. So we aimed to determine the function of miRNA-489 in cervical cancer proliferation and apoptosis in our present study. Interestingly, we found that miRNA-489 was significantly down-regulated in cervical cancer tissues. miRNA-489 overexpression inhibited the cell proliferation and improved the cell apoptosis of cervical cancer cells. Further, miRNA-489 over-expression suppressed the activation of PI3K and AKT, and stimulated P53 proteins expression. In conclusion, our results suggested that miRNA-489 may be considered as a biomarker in cervical cancer and had suppressed the cell proliferation and stimulated cell apoptosis via PI3K/AKT/P53 signaling pathway (Fig. 5, Ref. 26). Text in PDF www.elis.sk.

Entities:  

Keywords:  AKT; P53 biomarker.; PI3K; miRNA-489

Mesh:

Substances:

Year:  2018        PMID: 29749241     DOI: 10.4149/BLL_2018_052

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  12 in total

1.  LncRNA SNHG6 enhances the radioresistance and promotes the growth of cervical cancer cells by sponging miR-485-3p.

Authors:  Jin Liu; Xiaojiao Liu; Rong Li
Journal:  Cancer Cell Int       Date:  2020-08-31       Impact factor: 5.722

2.  Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.

Authors:  Runsheng Zhao; Jing Song; Yiqiang Jin; Yingying Liu
Journal:  J Mol Histol       Date:  2021-08-13       Impact factor: 2.611

3.  Lipid metabolism regulator human hydroxysteroid dehydrogenase-like 2 (HSDL2) modulates cervical cancer cell proliferation and metastasis.

Authors:  Yang Yang; Anna Han; Xinyue Wang; Xianglin Yin; Minghua Cui; Zhenhua Lin
Journal:  J Cell Mol Med       Date:  2021-03-18       Impact factor: 5.310

4.  MiR-3150b-3p inhibits the proliferation and invasion of cervical cancer cells by targeting TNFRSF11a.

Authors:  Zhijuan Yu; Liguo Wang; Xiujuan Li
Journal:  J Investig Med       Date:  2020-07-02       Impact factor: 2.895

5.  Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data.

Authors:  Yunan He; Shunjie Hu; Jiaojiao Zhong; Anran Cheng; Nianchun Shan
Journal:  PeerJ       Date:  2020-12-02       Impact factor: 2.984

6.  Baicalein Represses Cervical Cancer Cell Growth, Cell Cycle Progression and Promotes Apoptosis via Blocking AKT/mTOR Pathway by the Regulation of circHIAT1/miR-19a-3p Axis.

Authors:  Jiaojiao Hu; Runkun Wang; Yi Liu; Jianbo Zhou; Ka Shen; Yun Dai
Journal:  Onco Targets Ther       Date:  2021-02-09       Impact factor: 4.147

7.  FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression.

Authors:  Xiufang Yang; Huilan Du; Wenhui Bian; Qingxue Li; Hairu Sun
Journal:  Oncol Rep       Date:  2021-03-24       Impact factor: 3.906

8.  E6 hijacks KDM5C/lnc_000231/miR-497-5p/CCNE1 axis to promote cervical cancer progression.

Authors:  Yan Zhang; Xing Li; Jun Zhang; Lin Mao
Journal:  J Cell Mol Med       Date:  2020-08-20       Impact factor: 5.310

9.  MiR-362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathway.

Authors:  Shuya Yang; Yuanjie Sun; Dongbo Jiang; Jing Wang; Erle Dang; Zichao Li; Jiayi Zhou; Yuchen Lu; Jingqi Shi; Liang Tao; Jun Wang; Boquan Jin; Lianhe Zheng; Kun Yang
Journal:  Cancer Med       Date:  2020-11-19       Impact factor: 4.452

Review 10.  Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.

Authors:  Ningni Jiang; Qijie Dai; Xiaorui Su; Jianjiang Fu; Xuancheng Feng; Juan Peng
Journal:  Mol Biol Rep       Date:  2020-04-24       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.